Open AccessEpoprostenol‐associated ascites in pulmonary arterial hypertension
Author(s) -
Schoenberg Noah C.,
Ruopp Nicole F.,
Parikh Raj D.,
Farber Harrison W.
Publication year - 2022
Publication title -
pulmonary circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.791
H-Index - 40
ISSN - 2045-8940
DOI - 10.1002/pul2.12092
Subject(s) - medicine , ascites , cirrhosis , pulmonary hypertension , cardiology , portal hypertension , heart failure , hyperdynamic circulation , right heart failure , cardiac output , prostaglandin , hemodynamics
The development of ascites in pulmonary arterial hypertension (PAH) in the absence of pre‐existing hepatic dysfunction is usually associated with decompensated right heart failure or cardiac cirrhosis. Ascites in PAH has rarely been associated with intravenous epoprostenol, a synthetic form of the prostaglandin PGI 2 .